Relief Competitors
Relief Therapeutics competes with Delek Drilling, Penn National, Helmerich, AKITA Drilling, and Roblox Corp; as well as few others. Analyzing Relief Therapeutics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Relief Therapeutics to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Relief Therapeutics. Your research has to be compared to or analyzed against Relief Therapeutics' peers to derive any actionable benefits. When done correctly, Relief Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Relief Therapeutics. You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Relief Therapeutics competition on your existing holdings.
Relief |
Relief Therapeutics Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Relief Therapeutics and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Relief and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Relief Therapeutics does not affect the price movement of the other competitor.
0.38 | -0.66 | 0.14 | 0.71 | 0.0 | 0.52 | DKDRF | ||
0.38 | -0.24 | 0.34 | 0.08 | 0.0 | 0.34 | PENN | ||
-0.66 | -0.24 | 0.01 | -0.27 | 0.0 | -0.57 | HP | ||
0.14 | 0.34 | 0.01 | 0.11 | 0.0 | 0.1 | AKTAF | ||
0.71 | 0.08 | -0.27 | 0.11 | 0.0 | -0.04 | RBLX | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | NTGL | ||
0.52 | 0.34 | -0.57 | 0.1 | -0.04 | 0.0 | PBNAF | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Relief OTC Stock performing well and Relief Therapeutics OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Relief Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DKDRF | 1.05 | 0.44 | 0.00 | 2.58 | 0.00 | 3.85 | 10.84 | |||
PENN | 2.34 | 0.13 | 0.05 | 0.58 | 2.60 | 4.85 | 9.56 | |||
HP | 2.01 | (0.33) | 0.00 | (0.72) | 0.00 | 4.49 | 21.23 | |||
AKTAF | 1.09 | (0.13) | 0.00 | 2.10 | 0.00 | 2.54 | 9.19 | |||
RBLX | 1.84 | 0.43 | 0.16 | 0.62 | 2.42 | 4.40 | 19.13 | |||
NTGL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
PBNAF | 0.06 | 0.01 | 0.00 | 1.59 | 0.00 | 0.06 | 1.39 |
Relief Therapeutics Competitive Analysis
The better you understand Relief Therapeutics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Relief Therapeutics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Relief Therapeutics' competition over several years is one of the best ways to analyze its investment potential.Better Than Average | Worse Than Peers | View Performance Chart |
Relief Therapeutics Competition Performance Charts
Five steps to successful analysis of Relief Therapeutics Competition
Relief Therapeutics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Relief Therapeutics in relation to its competition. Relief Therapeutics' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Relief Therapeutics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Relief Therapeutics' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Relief Therapeutics, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Relief Therapeutics position
In addition to having Relief Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Management Thematic Idea Now
Management
Companies providing management services to businesses. The Management theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Management Theme or any other thematic opportunities.
View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Relief Therapeutics information on this page should be used as a complementary analysis to other Relief Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Relief OTC Stock
If you are still planning to invest in Relief Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Relief Therapeutics' history and understand the potential risks before investing.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Money Managers Screen money managers from public funds and ETFs managed around the world |